Two Nobel Prizes awarded in 2023 confirm that the modified RNA (mRNA) of COVID vaccines may contribute to the development of cancer.

The mRNA used in COVID-19 vaccines has been modified from its natural form to prevent the immune system from degrading it when injected. In a review of the literature published on 5 April 2024, two researchers awarded in 2023 with the Nobel, they write that that change causes immune suppression that can contribute to the development of cancer. Specifically, Katalinko Kariko, Ph.D., e Dr. Drew Weissman found that when uridine is changed to N1-methyl-pseudouridine (m1-psi), L’ mRNA does not degrade and proteins can be produced.